This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Mar;39(3):251-254.

doi: 10.1038/s41587-021-00850-6.

Bispecific antibodies poised to deliver wave of cancer therapies

Cormac Sheridan¹

Affiliations

PMID: 33692520
DOI: 10.1038/s41587-021-00850-6

Bispecific antibodies poised to deliver wave of cancer therapies

Cormac Sheridan. Nat Biotechnol. 2021 Mar.

. 2021 Mar;39(3):251-254.

doi: 10.1038/s41587-021-00850-6.

Author

Cormac Sheridan¹

Affiliation

¹ , Dublin, Ireland.

PMID: 33692520
DOI: 10.1038/s41587-021-00850-6

No abstract available

PubMed Disclaimer

Similar articles

A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.
Suurs FV, Lub-de Hooge MN, de Vries EGE, de Groot DJA. Suurs FV, et al. Pharmacol Ther. 2019 Sep;201:103-119. doi: 10.1016/j.pharmthera.2019.04.006. Epub 2019 Apr 24. Pharmacol Ther. 2019. PMID: 31028837 Review.
Bispecific Antibody Armed T Cells to Target Cancer Cells.
Thakur A, Lum LG, Mittal S. Thakur A, et al. Methods Mol Biol. 2018;1722:117-126. doi: 10.1007/978-1-4939-7553-2_8. Methods Mol Biol. 2018. PMID: 29264802
Recombinant bispecific antibodies for cancer therapy.
Kontermann RE. Kontermann RE. Acta Pharmacol Sin. 2005 Jan;26(1):1-9. doi: 10.1111/j.1745-7254.2005.00008.x. Acta Pharmacol Sin. 2005. PMID: 15659107 Review.
Bispecific antibodies for cancer therapy.
Chames P, Baty D. Chames P, et al. Curr Opin Drug Discov Devel. 2009 Mar;12(2):276-83. Curr Opin Drug Discov Devel. 2009. PMID: 19333873 Review.
Bispecific antibodies and ADCs: Once and future kings?
Reichert JM. Reichert JM. MAbs. 2011 Jul-Aug;3(4):329-30. doi: 10.4161/mabs.3.4.16589. Epub 2011 Jul 1. MAbs. 2011. PMID: 21654205 Free PMC article. No abstract available.

See all similar articles

Cited by

Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology.
Cherkasova EA, Chen L, Childs RW. Cherkasova EA, et al. Front Cell Infect Microbiol. 2024 Feb 6;14:1358470. doi: 10.3389/fcimb.2024.1358470. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38379771 Free PMC article. Review.
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Lucero OM, Lee JA, Bowman J, Johnson K, Sapparapu G, Thomas JK, Fan G, Chang BH, Thiel-Klare K, Eide CA, Okada C, Palazzolo M, Lind E, Kosaka Y, Druker BJ, Lydon N, Bowers PM. Lucero OM, et al. Clin Cancer Res. 2023 Oct 13;29(20):4230-4241. doi: 10.1158/1078-0432.CCR-22-0906. Clin Cancer Res. 2023. PMID: 37199721
Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager.
Xiao X, Cheng Y, Zheng X, Fang Y, Zhang Y, Sun R, Tian Z, Sun H. Xiao X, et al. Front Immunol. 2023 Apr 11;14:1113303. doi: 10.3389/fimmu.2023.1113303. eCollection 2023. Front Immunol. 2023. PMID: 37114050 Free PMC article.
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody.
Cramer DAT, Franc V, Heidenreich AK, Hook M, Adibzadeh M, Reusch D, Heck AJR, Haberger M. Cramer DAT, et al. MAbs. 2023 Jan-Dec;15(1):2175312. doi: 10.1080/19420862.2023.2175312. MAbs. 2023. PMID: 36799476 Free PMC article.
A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy.
Bordoloi D, Bhojnagarwala PS, Perales-Puchalt A, Kulkarni AJ, Zhu X, Liaw K, O'Connell RP, Park DH, Kulp DW, Zhang R, Weiner DB. Bordoloi D, et al. JCI Insight. 2022 Nov 22;7(22):e162553. doi: 10.1172/jci.insight.162553. JCI Insight. 2022. PMID: 36509287 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations
- scite Smart Citations